DSF@CuO gel induces mitochondrial dysfunction and triggers cuproptosis in lenvatinib-resistant hepatocellular carcinoma cells through the downregulation of DLAT, LIAS, and CDKN2A, while enhancing the expression of FDX1. The gene discussed is LIAS; the disease is hepatocellular carcinoma.